Jail study tests monthly shot to keep opioid treatment on track after release

NCT ID NCT06051890

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether starting a monthly extended-release buprenorphine injection (Sublocade) in jail helps people with opioid use disorder stay on treatment after release. Two hundred men entering jail with a daily buprenorphine prescription will be randomly assigned to either switch to the monthly shot or stay on daily pills. Researchers will track how many leave jail with at least 7 days of buprenorphine in their system and how many continue treatment in the community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Extended-release buprenorphine (Sublocade injection)

What this could lead to

If successful, this could show that starting a monthly buprenorphine shot in jail helps more people continue their opioid use disorder treatment after release, reducing relapse and overdose risk.

What could go wrong

This is a single-site study with 200 men, so results may not apply to all populations. The intervention requires starting in jail, which may not be feasible everywhere. Risks include injection site reactions and potential for diversion.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baystate Health

    RECRUITING

    Springfield, Massachusetts, 01199, United States

    Contact

  • Middlesex County House of Corrections

    RECRUITING

    New Brunswick, New Jersey, 08902, United States

    Contact Phone: •••-•••-••••

    Contact

  • NYU Langone Health - 180 Madison Ave

    RECRUITING

    New York, New York, 10016, United States

  • Tufts University Health Sciences

    RECRUITING

    Boston, Massachusetts, 02111, United States

    Contact